全文获取类型
收费全文 | 2802篇 |
免费 | 262篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 117篇 |
妇产科学 | 40篇 |
基础医学 | 360篇 |
口腔科学 | 69篇 |
临床医学 | 420篇 |
内科学 | 559篇 |
皮肤病学 | 50篇 |
神经病学 | 169篇 |
特种医学 | 118篇 |
外科学 | 313篇 |
综合类 | 95篇 |
一般理论 | 1篇 |
预防医学 | 317篇 |
眼科学 | 43篇 |
药学 | 238篇 |
中国医学 | 2篇 |
肿瘤学 | 158篇 |
出版年
2021年 | 24篇 |
2020年 | 19篇 |
2019年 | 42篇 |
2018年 | 43篇 |
2017年 | 28篇 |
2016年 | 36篇 |
2015年 | 53篇 |
2014年 | 68篇 |
2013年 | 91篇 |
2012年 | 118篇 |
2011年 | 131篇 |
2010年 | 72篇 |
2009年 | 85篇 |
2008年 | 132篇 |
2007年 | 134篇 |
2006年 | 152篇 |
2005年 | 147篇 |
2004年 | 104篇 |
2003年 | 122篇 |
2002年 | 106篇 |
2001年 | 97篇 |
2000年 | 81篇 |
1999年 | 74篇 |
1998年 | 63篇 |
1997年 | 63篇 |
1996年 | 64篇 |
1995年 | 48篇 |
1994年 | 33篇 |
1993年 | 35篇 |
1992年 | 57篇 |
1991年 | 49篇 |
1990年 | 44篇 |
1989年 | 53篇 |
1988年 | 51篇 |
1987年 | 47篇 |
1986年 | 49篇 |
1985年 | 54篇 |
1984年 | 32篇 |
1983年 | 29篇 |
1982年 | 24篇 |
1981年 | 19篇 |
1979年 | 26篇 |
1978年 | 22篇 |
1977年 | 22篇 |
1976年 | 22篇 |
1975年 | 29篇 |
1974年 | 16篇 |
1973年 | 19篇 |
1971年 | 15篇 |
1970年 | 22篇 |
排序方式: 共有3093条查询结果,搜索用时 15 毫秒
101.
102.
103.
Cibere J Thorne A Kopec JA Singer J Canvin J Robinson DB Pope J Hong P Grant E Lobanok T Ionescu M Poole AR Esdaile JM 《The Journal of rheumatology》2005,32(5):896-902
OBJECTIVE: To determine whether glucosamine sulfate has an effect on cartilage type II collagen degradation in patients with knee osteoarthritis (OA). METHODS: A randomized, double blind, placebo controlled glucosamine discontinuation trial was conducted in 137 subjects with knee OA, who had had at least moderate relief of knee pain after starting glucosamine. Subjects were randomized to glucosamine at prestudy dose or placebo at an equivalent dose. Treatment was continued to Week 24 or disease flare, whichever occurred first. Serum and urine samples were collected at Weeks 0, 4, 12, and 24 or flare visit. Samples were analyzed in triplicate for 2 type II collagen degradation biomarkers: C2C epitope (COL2-3/4C(long)) and C1,2C epitope (COL2-3/4C(short)). The primary outcome was the mean change in serum and urine C1,2C/C2C ratio in the glucosamine and placebo groups from baseline to final (flare or Week 24) visit. Linear regression analyses were conducted to adjust for potential confounders. Due to non-normal distributions, the data were log-transformed (lnC1,2C/C2C). Secondary outcomes included comparison of mean change scores at final visit compared to baseline for serum and urine C1,2C and C2C in the 2 treatment groups and in Flare versus No-Flare groups. RESULTS: Baseline and final visit samples were available in 130 subjects for serum analysis and 126 subjects for urinalysis. No significant difference was seen between placebo and glucosamine groups in the serum C1,2C/C2C ratio, with a mean (SD) change from baseline to final visit of 0.8 (27.8) and -0.1 (1.8), respectively (mean difference 0.9; 95% CI -6.0, 7.7, p = 0.80). Similarly, no differences between treatment groups were seen for mean change in urine C1,2C/C2C (p = 0.82), or for mean change in C2C or C1,2C. In linear regression analysis, after adjustment for sex, radiographic severity, baseline lnC1,2C/C2C ratio, WOMAC function, and flare status, treatment was not a significant predictor of final serum or urine lnC1,2C/C2C ratio. When those who experienced flare were contrasted with those without flare, there was a nonsignificant trend toward a difference in mean baseline to final visit change score for serum C1,2C/C2C ratio (p = 0.12). In addition, in the multivariable linear regression analysis, flare status showed a borderline association with final visit serum lnC1,2C/C2C ratio (p = 0.16). CONCLUSION: No statistically significant effect of glucosamine sulfate on type II collagen fragment levels in serum or urine was observed for knee OA over 6 months. Further research is necessary to elucidate which biopathologic systems, if any, are affected by glucosamine treatment. While collagen degradation products may be of value in predicting progression, at least as defined by clinical flare, a larger dataset would be needed to prove this. 相似文献
104.
105.
Nanet Willumsen Teresa Poole Jennifer M. Nicholas Nick C. Fox Natalie S. Ryan Tammaryn Lashley 《Brain pathology (Zurich, Switzerland)》2022,32(3)
Familial Alzheimer''s disease (FAD) is caused by autosomal dominant mutations in the PSEN1, PSEN2 or APP genes, giving rise to considerable clinical and pathological heterogeneity in FAD. Here we investigate variability in clinical data and the type and distribution of Aβ pathologies throughout the cortical layers of different FAD mutation cases. Brain tissue from 20 FAD cases [PSEN1 pre‐codon 200 (n = 10), PSEN1 post‐codon 200 (n = 6), APP (n = 4)] were investigated. Frontal cortex sections were stained immunohistochemically for Aβ, and Nissl to define the cortical layers. The frequency of different amyloid‐beta plaque types was graded for each cortical layer and the severity of cerebral amyloid angiopathy (CAA) was determined in cortical and leptomeningeal blood vessels. Comparisons were made between FAD mutations and APOE4 status, with associations between pathology, clinical and genetic data investigated. In this cohort, possession of an APOE4 allele was associated with increased disease duration but not with age at onset, after adjusting for mutation sub‐group and sex. We found Aβ pathology to be heterogeneous between cases although Aβ load was highest in cortical layer 3 for all mutation groups and a higher Aβ load was associated with APOE4. The PSEN1 post‐codon 200 group had a higher Aβ load in lower cortical layers, with a small number of this group having increased cotton wool plaque pathology in lower layers. Cotton wool plaque frequency was positively associated with the severity of CAA in the whole cohort and in the PSEN1 post‐codon 200 group. Carriers of the same PSEN1 mutation can have differing patterns of Aβ deposition, potentially because of differences in risk factors. Our results highlight possible influences of APOE4 genotype, and PSEN1 mutation type on Aβ deposition, which may have effects on the clinical heterogeneity of FAD. 相似文献
106.
Book reviews in this article: This paper describes the technique of total thyroidectomy using capsular dissection. Total thyroidectomy is a safe straightforward anatomical procedure in which meticulous dissection can provide protection to the parathyroid glands and to the recurrent laryngeal nerve. This protection is achieved by using capsular dissection, hugging the gland and dividing the tertiary branches (i.e. the third order of division) of the vessels while dissecting the parathyroid glands with their vascular pedicles free from the thyroid surface, with minimal exposure of the recurrent laryngeal nerve and disturbance of its blood supply. Total thyroidectomy removes all visible thyroid tissue although it is permissible to leave a very small remnant of tissue (less than a fraction of a gram) in the region of the ligament of Berry in order to protect the recurrent laryngeal nerve and the blood supply to the parathyroid glands. This technique ensures that the incidence of complications, including permanent hypoparathyroidism and recurrent laryngeal nerve palsy, is reduced to a minimum. 相似文献
107.
Mauro Alini Yasumoto Matsui George R. Dodge A. Robin Poole 《Calcified tissue international》1992,50(4):327-335
Summary Calcification occurs in the extracellular matrix of the hypertrophic zone of the growth plate when the extra-cellular matrix volume is reduced to a minimum and alkaline phosphatase content is maximal. The present study shows that significant quantitative and qualitative changes occur in the composition and structure of macromolecules in the extracellular matrix before and during calcification in the proximal tibial growth plate of the bovine fetus. These were detected in part by using microchemical and microimmuno-chemical analyses of sequential transverse frozen sections at chemical analyses of sequential transverse frozen sections at defined sites throughout the growth plate. Concentrations of matrix molecules in the extracellular matrix have not previously been determined biochemically. They were measured per unit matrix volume by using combined immunochemical/chemical-histomorphometric analyses. The concentrations within the extracellular matrix of the C-propeptide of type II collagen, aggregating proteoglycan (aggrecan), and hyaluronic acid all progressively increased in the maturing and hypertrophic zones, being maximal (or near maximal) at the time of initiation of mineralization. These results for proteoglycan are contrary to some earlier reports of a loss of proteoglycan prior to mineralization which measured the tissue content of proteoglycan rather than that present in the extracellular matrix, the volume of which is progressively reduced as the growth plate matures. The C-propeptide data provides a quantitative confirmation of previous immunohistochemical studies. Total collagen concentration (measured as hydroxyproline) in the extracellular matrix initially increased through the proliferating and maturing zones but then rapidly decreased in the hypertrophic zone. Immunohistochemical studies revealed that this is associated with the unwinding of the triple helix of type II collagen (previously shown to result from cleavage) which starts in pericellular sites in the zone of maturation (when type X collagen is first synthesized) and then extends throughout the hypertrophic zone. The significance of these matrix changes in the development and mineralization of the growth plate is discussed. 相似文献
108.
109.
110.
SP Walker M Permezel SF Berkovic 《BJOG : an international journal of obstetrics and gynaecology》2009,116(6):758-767
While most women with epilepsy can expect a normal pregnancy outcome, epilepsy remains a significant contributor to both maternal and perinatal morbidity. Pre-pregnancy planning must address reliable contraception and optimisation of antiepileptic drug (AED) regimens to minimise teratogenic risk while maintaining seizure control. The most recent data from the AED registries regarding malformations is presented in this review, as is the limited data on the newer AEDs and studies linking neurocognitive outcomes to AED exposure. During pregnancy, important considerations include; therapeutic drug monitoring, surveillance for obstetric complications and vigilance for seizures during the intrapartum and postpartum period. 相似文献